1. Home
  2. Bills
  3. S. 1813

S. 1813 · 117th Congress · 2021–2022

Accelerating Access to Critical Therapies for ALS Act

S. 1813 in the 117th Congress (2021–2022) was introduced on May 25, 2021, sponsored by Christopher A. Coons with 63 co-sponsors.

During the 117th Congress (2021–2022), Joe Biden was president, and Democrats held the House majority and Republicans the Senate majority.

Status
Introduced
Introduced
May 25, 2021
Co-sponsors
63
Policy area
Health

What it does

Accelerating Access to Critical Therapies for ALS Act This bill establishes grant programs to address neurodegenerative diseases, such as amyotrophic lateral sclerosis (also known as ALS or Lou Gehrig's disease), and contains other related provisions. The Department of Health and Human Services (HHS) shall award grants to eligible entities to facilitate patients' access to investigational drugs that diagnose or treat ALS.

Summary by the nonpartisan Congressional Research Service.

Sponsor

Christopher A. Coons (D-DE). Co-sponsors: 39 Democrats, 22 Republicans, 2 Independents.

Where it stands

  • IntroducedMay 25, 2021
  • Passed the Senate—
  • Passed the House—
  • Sent to the President—
  • Became law—

Latest action: Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (May 25, 2021)

More bills from Christopher A. Coons in the 117th Congress

Other Health bills in the 117th Congress

Committees

More

From GovInfo bill records, Congressional Research Service summaries, Voteview roll calls and lobbying reports.

Cite or embed this page

Capitol Receipts, “S. 1813 (117th Congress): Accelerating Access to Critical Therapies…,” https://www.capitolreceipts.com/bill/117-s-1813/accelerating-access-to-critical-therapies-for-als-act (accessed 2026-10-16).

Open the interactive version ›